Interaction of ciliary disease protein retinitis pigmentosa GTPase regulator with nephronophthisis-associated proteins in mammalian retinas by Murga-Zamalloa, Carlos A. et al.
Interaction of ciliary disease protein retinitis pigmentosa GTPase
regulator with nephronophthisis-associated proteins in
mammalian retinas
Carlos A. Murga-Zamalloa,1 Nimit J. Desai,1 Friedhelm Hildebrandt,2 Hemant Khanna1
1Department of Ophthalmology and Visual Sciences and Howard Hughes Medical Institute, University of Michigan, Ann Arbor,
MI; 2Department of Pediatrics and Human Genetics, University of Michigan, Ann Arbor, MI
Purpose: Retinitis pigmentosa GTPase regulator (RPGR) is a cilia-centrosomal protein that frequently mutates in X-
linked  retinal  degeneration  and  associated  disorders.  RPGR  interacts  with  multiple  ciliary  proteins  in  the  retina.
Perturbations in the assembly of RPGR complexes are associated with retinal degeneration. This study was undertaken
to delineate the composition and dissection of RPGR complexes in mammalian retinas.
Methods: Immunoprecipitation of RPGR from ciliary fraction of bovine retina was performed, followed by mass
spectrometry  analysis.  The  glutathione  S-transferase  pull-down  assay  was  performed  to  validate  the  interaction.
Immunodepletion experiments were performed to dissect the partitioning of RPGR in different protein complexes in
mammalian retinas.
Results: We found that RPGR associates with a ciliary protein nephrocystin-4 (nephroretinin; NPHP4) that is mutated in
nephronophthisis (NPH) and RP (Senior-Løken syndrome). This association is abolished in the Rpgr-knockout mouse
retina. The RCC1-like domain of RPGR interacts with the N-terminal 316 amino acids of NPHP4. In the retina, RPGR
also associates with NPHP1, an NPHP4-interacting protein; RPGR interacts directly with amino acids 243–586 of NPHP1.
We further show that, in the retina, RPGR associates with and is partitioned in at least two different complexes with NPHP-
associated proteins, (i) NPHP1, NPHP2, and NPHP5, and (ii) NPHP4, NPHP6, and NPHP8.
Conclusions: RPGR may regulate some complexes with NPHP proteins in the mammalian retina. The disruption of these
complexes may contribute to the pathogenesis of retinal degeneration in X-linked RP and associated ciliary diseases.
Primary  or  sensory  cilia  are  microtubule-based
extensions of the plasma membrane that are found in almost
all cell types [1,2]. They regulate diverse cellular processes,
including signal transduction, sensory perception, and protein
trafficking  [3].  Assembly  of  cilia  occurs  by  a  conserved
process called intraflagellar transport (IFT) [4]. During IFT,
precursor moieties are assembled at the base of the cilia (basal
bodies)  and  transported  in  anterograde  and  retrograde
directions by the kinesin-II and dynein motor subunits. The
transport  is  facilitated  by  the  multiple  IFT  polypeptides.
Defects  in  cilia  assembly  or  function  are  associated  with
multi-systemic disorders, including Senior-Løken syndrome
(SLSN), Bardet-Biedl syndrome, Joubert syndrome (JBTS),
and Meckel-Gruber syndrome [5,6].
Retinitis  pigmentosa  (RP;  OMIM  268000),  a
degenerative  disease  of  the  photoreceptors,  is  frequently
associated with ciliary dysfunction. RP is a clinically and
genetically heterogeneous group of disorders characterized by
severe vision loss and blindness [7]. X-linked RP (XLRP) is
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a common form of RP, accounting for 10%–15% of all RP
cases [8,9]. Clinical manifestations of XLRP usually include
night  blindness  due  to  rod  photoreceptor  dysfunction,
followed by loss of cone function and blindness by the fifth
decade of life [8,9]. Some female carriers also exhibit severe
retinal defects.
RP3, a major locus for XLRP, encodes for the retinitis
pigmentosa  GTPase  regulator  (RPGR)  gene  [10,11].
Mutations  in  RPGR  account  for  70%–80%  of  XLRP  and
~20% of simplex RP cases [12,13]. Some RPGR patients
exhibit  extra-retinal  phenotypes,  including  hearing
dysfunction,  sperm  defects,  respiratory  infections,  and
primary cilia dyskinesia [14–16]. The RPGR gene undergoes
extensive alternative splicing and expresses multiple protein
isoforms in the retina [17–20]. Most RPGR isoforms contain
a common N-terminal domain encoded by exons 1–15, which
encompass an RCC1-like domain (RLD; encoded by exons
2–11).  The  originally  described  constitutive  isoforms  of
RPGR are encoded by exons 1–19 and account for ~20% of
XLRP patients with no known mutations in exons 16–19.
Later studies revealed another isoform of RPGR that contains
an alternative terminal exon ORF15 (encompasses part of
intron 15). Mutations in exon ORF15 account for additional
50%–60% of XLRP patients.
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1373The RLD of RPGR is thought to be the functional domain
based  on  its  homology  to  RCC1  and  its  involvement  in
interaction  with  other  proteins.  RPGR  and  RPGR-RLD
predominantly localize to primary cilia and photoreceptor
connecting  cilium  (CC)  [19,21],  which  is  a  conduit  for
trafficking  of  proteins  from  the  inner  segment  to  the
photosensitive  outer  segment  [22].  An  Rpgr-knockout
(Rpgr-ko; deletion of exons 4–6 in RLD) mouse mutant [23],
which  was  later  shown  to  carry  a  hypomorphic  allele  of
Rpgr [19], exhibits delayed onset photoreceptor degeneration
and mistrafficking of cone opsins. In addition, two canine
models of RPGR mutation have been reported [24]. These
animal models exhibit disparate phenotypes depending upon
the type of mutation. Despite extensive efforts, it is still not
clear how RPGR regulates photoreceptor function or how
mutations in RPGR cause retinal degenerative disease.
Identification of RPGR-interacting proteins has played a
key role in understanding its function. RPGR interacts with
several ciliary and transport proteins in the retina, including
intraflagellar  transport  protein  IFT88/Polaris  and  RPGR-
interacting protein 1 (RPGRIP1) [19,25]. In addition, RPGR
associates  with  NPHP  proteins  mutated  in  renal  retinal
syndromes, including SLSN and JBTS [26–29]. For example,
RPGR  exists  in  complex  with  NPHP5  (or  IQ  domain
containing  calmodulin  binding  protein  [IQCB1];  SLSN),
centrosomal protein of 290 kDa (CEP290)/NPHP6 (Leber
congenital amaurosis, SLSN, JBTS), and NPHP8/RPGRIP1-
like  (RPGRIP1L;  mutated  in  JBTS  and  Meckel-Gruber
syndrome)  in  the  retina  [30–32].  Notably,  hypomorphic
mutations in NPHP6 and NPHP8, which are associated with
relatively early-onset photoreceptor degeneration [26–29,33–
35], disrupt their association with RPGR [30,31]. Based on
these  observations,  we  hypothesize  that  RPGR-containing
multiprotein  complexes  play  a  key  role  in  facilitating
photoreceptor protein trafficking.
To  elucidate  the  precise  role  of  RPGR  in  regulating
ciliary transport, it is important to identify and characterize
the  components  of  the  RPGR-interaction  network  in  the
retina.  Using  co-immunoprecipitation  (IP)  and  mass
spectrometry analysis, here we report that RPGR binds to
NPHP1 and NPHP4. Using serial immunodepletion, we also
found  that  the  RPGR-NPHP  interaction  network  can  be
divided into at least two distinct complexes: the first complex
constitutes NPHP1, NPHP2, and NPHP5, while the second
complex consists of NPHP4, NPHP6, and NPHP8.
METHODS
Animals: Animal experiments were performed in accordance
with the guidelines of the Institute for Laboratory Animal
Research  (Guide  for  the  Care  and  Use  of  Laboratory
Animals). Prior approval for animal studies was obtained from
the University of Michigan Animal Care and Use Committee.
ARVO's guidelines were followed for the care and use of
animals. The animals were fed ad libitum and were kept on a
12 h light and 12 h dark cycle. The background of the mice is
C57BL6/J.
Antibodies  and  reagents:  RPGR,  NPHP5,  and  CEP290/
NPHP6 antibodies have been previously described [19,30,
32].  Anti-NPHP1  antibody  was  purchased  from  Abcam.
Mouse  anti-NPHP2/Inversin  was  procured  from  Novus
Biologicals  (Littleton,  CO)  and  mouse  anti-NPHP4  was
obtained from Abnova (Taipei City, Taiwan).
Immunoprecipitation: Co-IP experiments were performed as
described [19]. Briefly, bovine (Detroit, MI) or mouse retinal
extracts  were  prepared  in  phosphate  buffered  saline
(KH2PO4: 1.76 mM; Na2HPO4: 10 mM; KCl: 2.7 mM; NaCl:
138 mM; pH: 7.4) followed by incubation with the primary
antibody  or  normal  IgG  (pre-immune  bleed  of  rabbits)
overnight at 4 °C. The protein-antibody complexes were then
incubated with protein A or protein G agarose beads for 30
min at room temperature with gentle shaking. The beads were
then washed with phosphate buffered saline with 1% (V/V)
Triton X-100 precipitated proteins and subjected to tandem
mass  spectrometry.  Dissection  of  complexes  by
immunodepletion (ID) was performed as described [36,37].
In  brief,  retina  protein  extract  was  subjected  to
immunoprecipitation using first primary antibody to deplete
the  associated  complexes.  The  supernatant  of  the
immunoprecipitation  was  then  incubated  with  the  second
primary antibody and the precipitated proteins were analyzed
by immunoblotting.
In  vitro  transcription/translation  and  glutathione  S-
transferase  pull  down:  Proteins  were  synthesized  in  vitro
using  the  Promega  (Madison,  WI)  TnT  Quick  kit  in  the
presence or absence of 35S-labeled methionine. Glutathione S-
transferase (GST) or GST-RLD proteins were purified from
E. coli and used in the GST pull-down assay, as described
[19].  The  35S-labeled  protein  signal  was  analyzed  by
autoradiography  with  STORM  840  (GE  Healthcare,
Piscataway, NJ). RPGR-RLD was cloned into pGEX4T-2
(GE Healthcare, Piscataway, NJ). cDNA encoding NPHP1,
NPHP4  and  deleted  domains  were  cloned  into  plasmid
pcDNA3.1 (Invitrogen, Carlsbad, CA) [19].
RESULTS
Retinitis  pigmentosa  GTPase  regulator  associates  with
nephrocystin-4:  To  identify  RPGR-interacting  proteins  in
mammalian  retinas,  we  performed  IP  using  anti-RPGR
antibody  followed  by  mass  spectrometry  analysis  of  the
precipitated  proteins.  Our  analysis  revealed  nephroretinin
(NPHP4) as a strong interactor of RPGR. NPHP4 is a cilia-
centrosomal protein mutated in nephronophthisis and SLSN
[38,39].  Given  that  NPHP4  interacts  with  RPGRIP1  and
NPHP8, and that it localizes to photoreceptor cilia [26,40], we
focused on further analyzing the physiologic relevance of
RPGR-NPHP4 interaction. Co-IP using anti-RPGR antibody
followed by detection of the NPHP4 immunoreactive band
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1374further confirmed that RPGR and NPHP4 exist in the same
complex in the retina (Figure 1A). Reverse IP using the anti-
NPHP4 antibody also revealed RPGR-immunoreactive bands
(data  not  shown).  IP  using  IgG  did  not  show  any
immunoreactivity.  To  examine  whether  RPGR-NPHP4
interaction is relevant to disease, we assessed the association
of RPGR and NPHP4 in the Rpgr-ko mouse retina. As we have
shown before, a deleted variant of RPGR is still expressed in
the  Rpgr-ko  mouse  retina  and  can  be  detected  using  the
RPGRORF15 antibody [19]. Using co-IP, we showed that the
mutant RPGR protein cannot associate with NPHP4 in the
retina. (Figure 1B). These results suggest that the RLD of
RPGR is involved in its interaction with NPHP4.
Retinitis pigmentosa GTPase regulator directly interacts with
nephrocystin-4:  To  test  whether  RPGR-RLD  interacts
directly with NPHP4, we performed a GST pull-down assay
using recombinant GST-RLD of RPGR and in vitro translated
NPHP4 (full length and different domains [Figure 1C]). Using
GST-RLD protein purified from E. coli and 35S-NPHP4, we
found that the RLD directly interacts with NPHP4 (Figure
1D). No interaction was detected when GST alone was used
in this experiment. We then sought to identify the domain of
NPHP4  that  interacts  with  RPGR-RLD.  To  this  end,  we
synthesized different 35S-labeled domains of NPHP4 (Figure
1C) and used in the GST pull-down assay. As shown in Figure
1E,  GST-RLD  can  interact  directly  with  N-terminal  316
amino acids (N316). An interaction is also detected with the
N1000- and N1186 domains of NPHP4.
Retinitis pigmentosa GTPase interacts with nephrocystin-1:
It  has  been  shown  that  NPHP4  interacts  with  NPHP1
(nephrocystin)  [41],  which  is  a  ciliary  protein  mutated  in
nephronophthisis  type  1  [42,43]  and  which  localizes  to
photoreceptor CC [44]. As NPHP4’s RPGR-binding domain
coincides with its NPHP1-binding domain [41], we tested
whether  RPGR  also  interacts  with  NPHP1.  Using  bovine
retinal extract, we found that the anti-RPGR antibody could
immunoprecipitate NPHP1 (Figure 2A). Reverse IP using
anti-NPHP1 antibody also revealed RPGR-immunoreactive
bands  (Figure  2B).  We  then  examined  the  interaction  of
RPGR with NPHP1 in vitro. Using 35S-labeled NPHP1 (full-
length and different domains [Figure 2C]) and GST-RLD
fusion protein, we showed that full-length NPHP1 directly
Figure 1. RPGR interacts with NPHP4. A: Bovine retinal lysate was subjected to IP using RPGR (A) antibody or control IgG (IgG from pre-
immune bleed of rabbits) followed by immunoblotting using anti-NPHP4 antibody. The input lane represents 20% of the protein used for IP.
B: The NPHP4-RPGR complex is disrupted in Rpgr-ko retinas: Protein lysates from wt or Rpgr-ko retinas were immunoprecipitated with
RPGR antibody and analyzed by immunoblotting with NPHP4 antibody. Lanes are indicated. C: Schematic representation of the primary
structure of NPHP4. BD represents the binding domain. D: Interaction of GST-RPGR with 35S in-vitro translated NPHP4 was analyzed by
GST pull-down assay, as described in the experimental procedures. Purified GST moiety was used as control. The lower panel shows
Coomassie blue stained gel of the GST-RPGR and GST protein (asterisks) used in the assay. E: The GST pull-down assay was performed
using GST-RPGR and 35S-labeled deletion mutants of NPHP4. The lower panel shows Coomassie blue staining of the GST-RPGR protein
used in this assay. Molecular markers in kDa are shown on the left.
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1375binds to RLD. No interaction is detected with GST alone
(Figure 2D). We also synthesized 35S-labeled NPHP1 domains
(Figure 2E) and used them in the GST-pull down assay. We
found that amino acids 243–586 of NPHP1 were sufficient
bind to RPGR-RLD (Figure 2F).
Retinitis  pigmentosa  GTPase  regulator  forms  distinct
complexes with nephrocystin proteins: All NPHP proteins
identified to date localize to cilia and centrosomes. In fact,
NPHP4  and  NPHP1,  identified  in  this  study  as  binding
partners of RPGR, have also been localized to photoreceptor
CC [40,44,45]. As RPGR is a cilia-centrosomal protein and
associates with the majority of NPHP proteins in the retina
(NPHP1, NPHP2, NPHP4, NPHP5, NPHP6, NPHP8, and
NPHP11) [46], we sought to determine how RPGR might be
partitioned in the NPHP complexes. We first performed serial
ID of NPHP4 or NPHP1 to immunodeplete the fraction of
RPGR that is in complex with these proteins. The remaining
RPGR in the supernatant was immunoprecipitated using anti-
RPGR  antibody  and  both  precipitates  were  tested  for  the
presence or absence of RPGR or other NPHP proteins. This
strategy  has  been  described  previously  [36,37]  and  is
schematically represented in Figure 3A. We first tested that
the  anti-NPHP4  antibody  is  efficient  in  immunodepleting
NPHP4.  Using  anti-NPHP4  antibody,  we  found  that  a
majority  (>90%)  of  NPHP4  is  immunodepleted  from  the
bovine  retinal  extracts  (Figure  3B;  sup  represents
supernatant). Using the NPHP4-immunodepleted supernatant
(NPHP4-ID sup), we performed IP using anti-RPGR antibody
and analyzed the precipitate for the presence of other NPHP
proteins. We found that the remaining RPGR still associated
with NPHP1, NPHP2, and NPHP5. However, NPHP6 and
NPHP8 were no longer detected in complex with RPGR in the
sample depleted of NPHP4 complexes (Figure 3C). Similar
results  were  obtained  when  NPHP2  and  NPHP5  were
immunodepleted  from  bovine  retinal  extracts  (data  not
shown). On the other hand, after ID of NPHP1 (Figure 4A),
RPGR still associated with NPHP4, NPHP6, and NPHP8, but
not with NPHP2 or NPHP5 (Figure 4B). Taken together, our
data indicate that there are at least two different RPGR-NPHP
complexes:  (i)  RPGR-NPHP1-NPHP2-NPHP5  and  (ii)
RPGR-NPHP4-NPHP6-NPHP8.
Retinitis  pigmentosa  GTPase  regulator-nephrocystin-4
complex  is  distinct  from  nephrocystin-1-nephrocystin-4
complex: We have found that the previously reported NPHP1-
binding domain of NPHP4 coincides with its RPGR-binding
domain.  Hence,  we  hypothesized  that  RPGR-NPHP4
complexes are distinct from NPHP4-NPHP1 complexes. As
shown above, after serial ID of NPHP1, NPHP4 can still
associate  with  RPGR.  We  then  examined  whether  ID  of
RPGR abolishes the NPHP1-NPHP4 complexes. Our analysis
revealed that even when the majority of RPGR was depleted,
NPHP4 still associated with NPHP1 (Figure 5A-C). These
results indicate that there are potentially RPGR-independent
NPHP1-NPHP4 complexes in the retina.
Figure 2. RPGR interacts with NPHP1. A, B: The association of RPGR with NPHP1 in bovine retina was analyzed by co-IP using appropriate
antibodies. Precipitated proteins were analyzed by SDS–PAGE followed by immunoblotting with the indicated antibodies. C: Schematic
representation of the primary structure of NPHP1. Abbreviations: NHD represents the nephrocystin homology domain; BD represents the
binding domain; SH3 represents the Src homology domain. D: Interaction of GST-RPGR with 35S NPHP1 was analyzed by GST pull-down
assay. Amount of GST bound proteins was evaluated by Coomassie blue staining (asterisk; lower panel). E: This panel denotes expression
of different domains of 35S-NPHP1 (asterisks) used in the GST pull-down assay. Gels were analyzed by autoradiography. F: The interaction
of different domains of NPHP1 with RPGR was analyzed by GST pull-down assay. Coomassie blue staining of the gels loaded with GST-
RPGR protein was performed to evaluate the amount of protein in each experiment (lower panel). Molecular weight markers in kDa are shown
on the left. Arrows indicate the specific protein bands representing the 35S-NPHP1 deleted domains.
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Ciliopathies  are  accompanied  by  overlapping  as  well  as
somewhat distinct phenotypes, although they arise from a
common defect in ciliary functions [47]. Nephronophthisis, a
ciliopathy characterized by fibrocystic renal disease, is the
leading genetic cause of end stage renal disease in children
and  young  adults  [6].  The  syndromic  disorder  SLSN  is
characterized by nephronophthisis and retinal degeneration.
To date, 10 NPHP genes have been identified as causing
NPHP  or  SLSN  of  variable  severities  (NPHP1–9  and
NPHP11) [26,27,29,32,38,42,43,48–52]. All NPHP proteins
localize to primary cilia and photoreceptor sensory cilia [5,6,
53]. Degeneration of photoreceptors is a commonly observed
phenotype in ciliopathies. However, the mechanism of the
progression and pathogenesis of photoreceptor degeneration
due  to  mutations  in  ciliary  proteins  is  not  completely
understood.  Here,  we  describe  the  network  of  ciliary
complexes of RPGR and NPHP proteins in mammalian retina
that  may  be  altered  in  disease  condition.  Our  work  has
revealed important findings. First, we described NPHP4 and
NPHP1  as  novel  RPGR-interacting  proteins  in  the  retina.
Second,  we  showed  that  RPGR  and  NPHP  proteins  form
Figure 3. Immunodepletion of NPHP4 in bovine retina. A: Schematic
representation of the procedure used for ID/IP experiments. B: About
500 mg of bovine retinal lysate was subjected to IP using anti-NPHP4
antibody. Precipitated (pellet) as well as supernatant samples were
analyzed by immunoblotting using NPHP4 antibody. C: NPHP4-
immunodepleted supernatant (NPHP4-ID sup) was subjected to IP
with anti-RPGR antibody followed by immunoblot analysis using
the indicated antibodies. Molecular weight markers in kDa are shown
on the left.
distinct complexes in the retina. Third, we demonstrated that
the RLD of RPGR might mediate RPGR-NPHP interactions.
Figure 4. Immunodepletion of NPHP1 in bovine retinas. A: NPHP1-
containing complexes were immunodepleted from bovine retinal
lysates, as described above. The supernatant (sup) was subsequently
used for IP experiments. B: NPHP1-immunodepleted supernatant
(NPHP1-ID  sup)  was  subjected  to  IP  with  anti-RPGR  antibody
followed by immunoblot analysis. Lanes are indicated. Molecular
weight markers in kDa are shown on the left.
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Figure 5. NPHP1 and NPHP4 interact independently of RPGR. A:
Bovine  retinal  lysates  were  subjected  to  IP  using  anti-RPGR
antibody followed by immunoblotting of the precipitated proteins
and  supernatant  (sup).  B,  C:  RPGR-immunodepleted  RPGR
supernatant (RPGR-ID sup) was immunoprecipitated with either
anti-NPHP4 (B) or anti-NPHP1 (C) antibodies and analyzed by
SDS–PAGE and immunoblotting. Lanes are indicated. Molecular
weight markers in kDa are shown on the left.
interactions  are  altered  in  the  mouse  mutant  of  Rpgr.  As
RPGR and its interacting proteins have been shown to play a
key role in regulating protein trafficking in photoreceptors,
our data point to a role of RPGR-NPHP protein complexes in
cilia-dependent transport and associated disease.
It has been shown that NPHP1 and NPHP4 interact with
each  other  in  renal  epithelial  cells  [41].  Although  RPGR
interacts with both NPHP1 and NPHP4, our data suggest that
RPGR-NPHP4 and RPGR-NPHP1 complexes may be distinct
from the NPHP1-NPHP4 complexes in the retina. We have
recently shown that knockdown of RPGR results in shorter
cilia in the Kupffer’s vesicles of zebrafish [54]. Interestingly,
Mollet  et  al.  [41]  reported  that  knockdown  of  NPHP1  or
NPHP4  also  results  in  shorter  cilia.  Cumulatively,  these
studies  provide  further  evidence  for  a  functional  overlap
between  RPGR  and  NPHP  proteins  in  regulating
photoreceptor function.
What is the function of RPGR-NPHP complexes? As
photoreceptors rely almost completely on the primary cilium
for microtubule-based intersegmental transport of proteins
involved  in  phototransduction  and  outer  segment  renewal
[22,55–58], slight perturbations in protein trafficking can lead
to photoreceptor degeneration and blindness [30,59–61]. Our
data suggest that distinct protein complexes may facilitate the
binding,  trafficking,  and  release  of  the  cargo  moieties  at
different  steps  of  the  protein  transport  pathways.  A
communication or “hand over” mechanism may exist between
the distinct protein complexes for efficient cargo transfer and
delivery. RPGR seems to play a key role in regulating a subset
of  these  complexes  in  photoreceptors.  The  degree  of
disruption of individual complexes at particular steps of the
protein  transport  pathways  may  determine  the  severity  of
associated disease. Further studies are required to assess the
physiologic relevance and functionality of these complexes in
protein trafficking in photoreceptors.
Ciliopathies exhibit clinical heterogeneity even within
single families. The present studies suggest the involvement
of genetic modifiers of the disease phenotype. We recently
showed that mutations in NPHP8, which alter its interaction
with RPGR, act as modifiers of the expressivity of the retinal
degeneration  phenotype  in  ciliopathy  patients  [31].  More
recently, it has been reported that mutations in Abelson helper
integration site 1 protein homolog (AHI1), which interacts
with NPHP1 [62], act as modifier of retinal degeneration
phenotype  in  nephronophthisis  [63].  Taken  together,  the
RPGR-interactome dissected in this study provides clues to
further  analyze  the  molecular  mechanisms  underlying  the
genetic  and  clinical  heterogeneity  associated  with
ciliopathies.
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